Herbal extract shows promise in calming schizophrenia inflammation
NCT ID NCT07575516
First seen May 09, 2026 · Last updated May 09, 2026
Summary
This study tested whether adding ashwagandha extract to standard schizophrenia treatment (risperidone) can lower inflammation and improve symptoms. 80 men with schizophrenia took part. Researchers measured changes in a blood marker for inflammation (IL-1β) and symptom scores. The goal was to see if ashwagandha could be a helpful add-on therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROINFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
South Sulawesi Mental Hospital (RSKD Dadi)
Makassar, South Sulawesi, 90245, Indonesia
Conditions
Explore the condition pages connected to this study.